Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email
Dr. Monica Zamisch

Monica Zamisch, Ph.D.

  • Program Director
240-276-7311 |

Dr. Monica Zamisch has expertise in cancer immunology, molecular biology, vaccine development, and systems biology. She manages a portfolio of grants  focusing primarily on the adaptive immune system and how to improve and potentiate the immune response against tumors.  

Along with her DCB responsibilities, she leads the NIH Targeted Delivery Interest Group.

 

Research Programs

Dr. Zamisch also helps manage a DCB cooperative agreement program:

 

Background

Prior to DCB, Dr. Zamisch worked as a program officer at the National Institute of Allergy and Infectious Diseases (NIAID) and as a Systems Engineering and Technical Assistant at the Defense Advanced Research Projects Agency (DARPA).

 

Education

  • Ph.D., Cancer Biology and Immunology, University of Texas MD Anderson Cancer Center Graduate School
  • B.S, Biochemistry, University of the Republic, Uruguay 


     
 

  • Updated:
Email